Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
基本信息
- 批准号:10242213
- 负责人:
- 金额:$ 35.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-19 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:ATP HydrolysisAcuteAddressAdenosine TriphosphateAffectAgeAnnexinsBinding ProteinsBiochemicalBioenergeticsBiologicalBlood flowCellsChargeClinicalCompartment syndromesCoronary OcclusionsDataDevelopmentDistalDropsDyesEnsureEvans blue stainExhibitsExperimental DesignsExposure toFlexorFree EnergyGenerationsGenesGeneticGlycogenGoalsGrantHemorrhageHindlimbHourHumanHypoxiaIschemiaLimb structureLongevityMaintenanceMembraneMetabolicModelingMolecularMuscleMuscle functionMyoblastsMyocardiumMyopathyNecrosisOxygenPathologyPatientsPeripheralPeripheral arterial diseasePhenotypePhysiologicalPlayPre-Clinical ModelPredispositionProductionProteinsProteomicsReactionRegulationResistanceRoleSLC2A1 geneSarcolemmaSiteSkeletal MuscleSoleus MuscleSystemTherapeuticTissue SurvivalTissuesWalkingartery occlusionbasedesignexcitotoxicityexperienceexperimental studyextensor digitorumfemoral arteryfunctional independencegain of functionimprovedin vivoischemic injurylimb injurylimb ischemialoss of functionmortalitymouse modelnew therapeutic targetnovelnovel therapeutic interventionpreservationpreventskeletal muscle wastingtherapeutic target
项目摘要
Abstract/Project Summary
Dogma tells us that oxygen (O2) is an absolute requirement for cell/tissue survival. We have recently
discovered a unique skeletal muscle that is remarkably and uniquely resistant to negative effects of ischemia.
The implication is that unlike other peripheral skeletal muscles, this muscle has a distinct mechanism that
allows it to tolerate ischemic conditions. Identifying the underlying mechanism(s) that explain the ischemia
resistance could hold the key to unlocking therapeutic targets and/or approaches for improving tissue survival
under conditions where O2 exposure is limiting. Ischemia affects skeletal muscle in numerous clinical
conditions, including various myopathies, peripheral artery disease (PAD), compartment syndrome, severe
limb injury, etc., not to mention coronary occlusion in cardiac muscle. Thus, the identification of a mechanism
that provides ischemia resistance would overcome one of the longest standing challenges faced by clinicians.
Using an integrative experimental design, the scientific goal of this project is to elucidate the unique
functional, metabolic, and/or bioenergetic systems that account for the ability of this muscle to survive ischemic
insults. The long-term goal of the project is to leverage the identified mechanism(s) to therapeutically treat
and/or prevent myopathies induced or exacerbated by ischemia. The proposal will use molecular, biochemical,
and physiological approaches designed to address hypotheses grounded in the idea that this unique muscle
must be able to meet energetic demands and ensure sarcolemmal stability during ischemia. Thus, the
experimental approach seeks to leverage already identified genes that are critical to the generation of
adenosine triphosphate and manipulate genes that are able to stabilize the sarcolemma during ischemic
conditions to prevent excitotoxicity. Using gain-of or loss-of function approaches the experiments designed in
the proposal will determine if the mechanism is necessary for ischemia survival and also assess if the
mechanism is sufficient to survive ischemia. Completion of this proposal will challenge dogma concerning our
understanding of how tissue can resist ischemic insults and advance the field forward in a significant fashion
due to the identification of an ischemia-resistant muscle.
摘要/项目摘要
教条告诉我们,氧气(O2)是细胞/组织生存的绝对必需品。我们最近
发现了一种独特的骨骼肌,它对局部缺血的负面影响有着显著而独特的抵抗力。
这意味着,与其他外周骨骼肌不同,这种肌肉有一种独特的机制,
使其能够耐受缺血性条件。确定解释缺血的潜在机制
耐药性可能是打开治疗靶点和/或改善组织存活的方法的关键
在氧气暴露受到限制的条件下。缺血影响骨骼肌在许多临床
疾病,包括各种肌病、外周动脉疾病(PAD)、筋膜室综合征、严重
肢体损伤等,更不用说心肌中的冠状动脉阻塞了。因此,确定一种机制
提供抗局部缺血性将克服临床医生面临的最长期的挑战之一。
使用综合实验设计,该项目的科学目标是阐明独特的
功能、代谢和/或生物能量系统,这些系统解释了这种肌肉在缺血性损伤中存活的能力。
侮辱。该项目的长期目标是利用已确定的机制来治疗
和/或预防由局部缺血诱发或加重的肌病。该提案将使用分子,生物化学,
和生理学方法来解决基于这种独特的肌肉
必须能够满足能量需求并确保局部缺血期间肌膜的稳定性。因此
实验方法试图利用已经确定的基因,这些基因对产生
腺苷三磷酸和操纵基因,能够稳定肌膜在缺血
防止兴奋性毒性的条件。使用增益或损失的功能方法的实验设计,
该提案将确定该机制是否是缺血存活所必需的,
机制足以在缺血中存活。完成这项建议将挑战有关我们的教条,
了解组织如何能够抵抗缺血性损伤,并以一种重要的方式向前推进该领域
这是由于抗缺血肌肉的鉴定。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hypoxia Resistance Is an Inherent Phenotype of the Mouse Flexor Digitorum Brevis Skeletal Muscle.
- DOI:10.1093/function/zqad012
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Skeletal muscle undergoes fiber type metabolic switch without myosin heavy chain switch in response to defective fatty acid oxidation.
- DOI:10.1016/j.molmet.2022.101456
- 发表时间:2022-05
- 期刊:
- 影响因子:8.1
- 作者:Pereyra AS;Lin CT;Sanchez DM;Laskin J;Spangenburg EE;Neufer PD;Fisher-Wellman K;Ellis JM
- 通讯作者:Ellis JM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ESPEN E SPANGENBURG其他文献
ESPEN E SPANGENBURG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ESPEN E SPANGENBURG', 18)}}的其他基金
Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
- 批准号:
10084061 - 财政年份:2020
- 资助金额:
$ 35.63万 - 项目类别:
Walk this way: leveraging of a unique skeletal muscle that is resistant to ischemic injury
沿着这条路走:利用独特的抗缺血性损伤的骨骼肌
- 批准号:
10897684 - 财政年份:2020
- 资助金额:
$ 35.63万 - 项目类别:
BRCA1 is necessary for optimal skeletal muscle function
BRCA1 对于最佳骨骼肌功能是必需的
- 批准号:
8886653 - 财政年份:2015
- 资助金额:
$ 35.63万 - 项目类别:
BRCA1 is necessary for optimal skeletal muscle function
BRCA1 对于最佳骨骼肌功能是必需的
- 批准号:
9753702 - 财政年份:2015
- 资助金额:
$ 35.63万 - 项目类别:
The role of BRCA1 in regulation of lipid metabolism in skeletal muscle
BRCA1在骨骼肌脂质代谢调节中的作用
- 批准号:
8112903 - 财政年份:2011
- 资助金额:
$ 35.63万 - 项目类别:
The role of BRCA1 in regulation of lipid metabolism in skeletal muscle
BRCA1在骨骼肌脂质代谢调节中的作用
- 批准号:
8286172 - 财政年份:2011
- 资助金额:
$ 35.63万 - 项目类别:
Regulation of skeletal alpha actin expression during mu*
mu* 期间骨骼 α 肌动蛋白表达的调节
- 批准号:
7198071 - 财政年份:2006
- 资助金额:
$ 35.63万 - 项目类别:
Regulation of skeletal alpha actin expression during mu*
mu* 期间骨骼 α 肌动蛋白表达的调节
- 批准号:
7031397 - 财政年份:2006
- 资助金额:
$ 35.63万 - 项目类别:
Regulation of skeletal alpha actin expression during mu*
mu* 期间骨骼 α 肌动蛋白表达的调节
- 批准号:
7434515 - 财政年份:2006
- 资助金额:
$ 35.63万 - 项目类别:
Leukemia inhibitor factor in skeletal muscle regrowth
骨骼肌再生中的白血病抑制因子
- 批准号:
6445216 - 财政年份:2002
- 资助金额:
$ 35.63万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 35.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 35.63万 - 项目类别:
Operating Grants